Naturalistic
Included: ≥2-y History of
moderate SAR
Excluded: Sinusitis
(≥2 episodes in past 2 y),
ongoing rhinitis
medicamentosa
N = 722;
479 women,
243 men; mean
age, 35 y (range,
12–84 y)
DL 5 mg/d
for 15 d
FEX 180 mg/d
for 15 d
PBO
Subjective (subject-rated instantaneous and
reflective TSS)
Morning/evening reflective individual nasal
congestion score significantly reduced with DL
and FEX vs PBO (both, P = 0.013)